Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
MetaOptics signs deal to deploy direct laser writer at Stanford nano facility

MetaOptics signs deal to deploy direct laser writer at Stanford nano facility

ReutersReuters2026/08/12 23:21
  • MetaOptics signed an agreement to install and deploy its metalens Direct Laser Writer at Stanford’s nano@stanford facility.
  • System targets 4-inch glass wafers for weeks-long prototyping, small-volume production, pilot builds, and customer demand evaluation.
  • nano@stanford will manage access for members, provide user feedback, support demonstrations, and validate the equipment in a shared-use environment.
  • Direct Laser Writer uses 100 nm precision, enabling simultaneous fabrication of more than 100 metalenses as small as 0.1 mm diameter.
  • Deployment supports a “mini foundry” footprint in Silicon Valley, tied to MetaOptics’ U.S. expansion and SystemX Alliance engagement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metaoptics Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 31SQEFYWRGWT9WLL) on August 12, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas